Midgard Science
Z

Zepteon

Boston, MA, United States zepteon.com From their website, Nov 2026

Work here? Claim this listing

About

ZEPTEON develops chromatography resins and affinity purification technology for separating antibodies and Fc-fusions by glycoform and subclass. It serves researchers and developers working on monoclonal antibodies, biosimilars, IVIG, and related therapeutics. The company is based in Boston, Massachusetts, and was established in 2012.

Services

  • Glycap-3A affinity purification resin

    Provides a chromatography resin for separating antibodies based on glycoform and subclass, including nonfucosylated and bisected GlcNAc species.

  • Antibody glycoform separation

    Enables separation of antibodies with specific glycoforms to support analysis and development of antibody therapeutics.

  • Fc-fusion separation

    Supports separation of Fc-fusion proteins using its glycoform- and subclass-based affinity technology.

  • Biosimilars development support

    Helps biosimilar developers tune fucose levels and compare structure:function relationships with innovator molecules.

  • IVIG enrichment and depletion

    Enables enrichment or depletion of immune-activating glycoforms or subclasses in plasma-derived intravenous immunoglobulin.

Capabilities

Assays and studies
  • Antibodies
  • In vivo
  • Structure:function studies
  • Receptor binding comparison
  • In vitro function studies
  • In vivo function studies
Therapeutic areas
  • Infectious diseases
  • Cancer
  • Autoimmunity
  • Rare diseases

Instruments and platforms

  • Chromatography resins
  • Affinity purification resin

Modalities and species

Modalities
  • Antibody
  • mRNA
  • Cell therapy
  • Recombinant protein
  • Biosimilar
  • LNP / formulation

Certifications

As the company states them, with the certificate or registry record where there is one.

  • GMPSelf-reported

Details

Founded
2012
Based in
Boston, MA, United States

Similar labs